Skip to main content

Focus of Study: Radiolabel Recovery and Survival of RBCs

1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Terumo Medical
Terumo MedicalGermany - Leverkusen
1 program
1
Mirasol System for Whole BloodPhase 11 trial
Active Trials
NCT01907906Completed29Est. May 2014

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Terumo MedicalMirasol System for Whole Blood

Clinical Trials (1)

Total enrollment: 29 patients across 1 trials

NCT01907906Terumo MedicalMirasol System for Whole Blood

Inactivation of Whole Blood With Mirasol

Start: Jun 2013Est. completion: May 201429 patients
Phase 1Completed

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.